305 related articles for article (PubMed ID: 11212260)
1. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
Watson SA; Smith AM
Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
[TBL] [Abstract][Full Text] [Related]
2. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R
Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983
[TBL] [Abstract][Full Text] [Related]
3. Apc mice: models, modifiers and mutants.
McCart AE; Vickaryous NK; Silver A
Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487
[TBL] [Abstract][Full Text] [Related]
4. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.
Hassan AB; Howell JA
Cancer Res; 2000 Feb; 60(4):1070-6. PubMed ID: 10706126
[TBL] [Abstract][Full Text] [Related]
6. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
8. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
[TBL] [Abstract][Full Text] [Related]
10. APC in the regulation of intestinal crypt fission.
Wasan HS; Park HS; Liu KC; Mandir NK; Winnett A; Sasieni P; Bodmer WF; Goodlad RA; Wright NA
J Pathol; 1998 Jul; 185(3):246-55. PubMed ID: 9771477
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
[TBL] [Abstract][Full Text] [Related]
12. Immunodetection of the presence or absence of full-length APC gene product in human colonic tissues.
Chop AM; Abraham CL; Adrian TE; Murphy R; Boman BM
Anticancer Res; 1995; 15(3):991-7. PubMed ID: 7645991
[TBL] [Abstract][Full Text] [Related]
13. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.
Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A
Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967
[TBL] [Abstract][Full Text] [Related]
14. The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors.
Modica S; Gofflot F; Murzilli S; D'Orazio A; Salvatore L; Pellegrini F; Nicolucci A; Tognoni G; Copetti M; Valanzano R; Veschi S; Mariani-Costantini R; Palasciano G; Schoonjans K; Auwerx J; Moschetta A
Gastroenterology; 2010 Feb; 138(2):636-48, 648.e1-12. PubMed ID: 19818784
[TBL] [Abstract][Full Text] [Related]
15. beta-Catenin-accumulated crypts in the colonic mucosa of juvenile ApcMin/+ mice.
Hata K; Tanaka T; Kohno H; Suzuki R; Qiang SH; Yamada Y; Oyama T; Kuno T; Hirose Y; Hara A; Mori H
Cancer Lett; 2006 Jul; 239(1):123-8. PubMed ID: 16168560
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
[TBL] [Abstract][Full Text] [Related]
17. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer.
Watson SA; Michaeli D; Grimes S; Morris TM; Robinson G; Varro A; Justin TA; Hardcastle JD
Cancer Res; 1996 Feb; 56(4):880-5. PubMed ID: 8631028
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
Perkins S; Verschoyle RD; Hill K; Parveen I; Threadgill MD; Sharma RA; Williams ML; Steward WP; Gescher AJ
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):535-40. PubMed ID: 12050094
[TBL] [Abstract][Full Text] [Related]
19. A mouse model of human familial adenomatous polyposis.
Yang K; Edelmann W; Fan K; Lau K; Kolli VR; Fodde R; Khan PM; Kucherlapati R; Lipkin M
J Exp Zool; 1997 Feb; 277(3):245-54. PubMed ID: 9062998
[TBL] [Abstract][Full Text] [Related]
20. Growth stimulation of intestinal tumours in Apc(Min/+) mice by dietary L-methionine supplementation.
Paulsen JE; Alexander J
Anticancer Res; 2001; 21(5):3281-4. PubMed ID: 11848484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
